| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f0fcce2823e49658311046582f86dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2993051beef8a2f0934d25016304a02 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H02G3-0481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2307-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-1369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2307-3065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2457-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2250-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2476
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2262-0276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-24752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-1362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B5-024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B5-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B7-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B32B3-00 |
| filingDate |
2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74df0b6c9daa37ece0e448717b6686a1 |
| publicationDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007079400-A8 |
| titleOfInvention |
Self-adhesive protective substrate |
| abstract |
The present invention relates to compounds and methods useful as inhibitors of protein kinases, including B-Raf and several receptor tyrosine and cytoplasmic tyrosine kinases. The present invention is directed to new substituted pyrimidinyloxy urea compounds of Formulas II, III and IV and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulating of protein kinase activity in a human or animal subject are also provided for the treatment diseases such as cancers. |
| priorityDate |
2005-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |